Q3 2024 · 13F-HR
Mubadala Investment Co PJSCholdings as filed
Filed 2024-11-13 · accession 0001085146-24-005580
$18.83B
Reported value
14
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G39387108 | GFS | GLOBALFOUNDRIES INC | $18.13B | 96.3% | 450,387,613 | Common | SOLE |
| 042068205 | ARM | ARM HOLDINGS PLC | $214.8M | 1.14% | 1,501,960 | Common | SOLE |
| 15687V109 | CERT | CERTARA INC | $112.6M | 0.60% | 9,615,384 | Common | SOLE |
| 75629V104 | RXRX | RECURSION PHARMACEUTICALS IN | $85.6M | 0.45% | 12,985,927 | Common | SOLE |
| 04040Y109 | ARIS | ARIS MNG CORP | $72.5M | 0.38% | 15,750,000 | Common | SOLE |
| 65342K105 | NEXT | NEXTDECADE CORP | $66.9M | 0.36% | 14,206,376 | Common | SOLE |
| 29260Y109 | 0C3 | ENDEAVOR GROUP HLDGS INC | $63.8M | 0.34% | 2,232,747 | Common | SOLE |
| 88546E105 | TWKSEUR | THOUGHTWORKS HOLDING INC | $34.4M | 0.18% | 7,777,762 | Common | SOLE |
| 22266T109 | CPNG | COUPANG INC | $24.6M | 0.13% | 1,000,000 | Common | SOLE |
| 30050E105 | EVO | EVOTEC AG | $16.8M | 0.09% | 4,597,701 | Common | SOLE |
| N97284108 | NBIS | NEBIUS GROUP N.V. | $10.2M | 0.05% | 539,751 | Common | SOLE |
| 690145107 | OMGBP | OUTSET MED INC | $975,287 | 0.01% | 1,440,601 | Common | SOLE |
| 29415B103 | EVAUSD | ENVIVA INC | $191,280 | 0.00% | 472,529 | Common | SOLE |
| G6529J118 | GDEVW | GDEV INC | $110,999 | 0.00% | 2,219,970 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.